Overview

Drug Interaction Study Between AZD3480 and Cytochrome P450

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate if AZD3480 inhibits Cytochrome P450 1A2, 2C19, 3A4, 2C8, 2B6 and UGT1A1 activity.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Bilirubin
Bupropion
Caffeine
Midazolam
Omeprazole
Rosiglitazone